BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 15448763)

  • 1. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
    Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
    Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
    J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction and oxidative stress in chronic renal failure.
    Ghiadoni L; Cupisti A; Huang Y; Mattei P; Cardinal H; Favilla S; Rindi P; Barsotti G; Taddei S; Salvetti A
    J Nephrol; 2004; 17(4):512-9. PubMed ID: 15372412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
    Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
    Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
    De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
    Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
    Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S
    J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with increased plasma homocysteine in patients using an amino acid peritoneal dialysis fluid.
    Yang SY; Huang JW; Shih KY; Hsu SP; Chu PL; Chu TS; Wu KD
    Nephrol Dial Transplant; 2005 Jan; 20(1):161-6. PubMed ID: 15572386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis.
    Mahajan S; Kalra OP; Asit KT; Ahuja G; Kalra V
    Ren Fail; 2005; 27(4):357-60. PubMed ID: 16060119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of toxic metals in blood and urine samples of chronic renal failure patients, before and after dialysis.
    Kazi TG; Jalbani N; Kazi N; Jamali MK; Arain MB; Afridi HI; Kandhro A; Pirzado Z
    Ren Fail; 2008; 30(7):737-45. PubMed ID: 18704823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress markers in pre-uremic patients.
    Annuk M; Fellström B; Akerblom O; Zilmer K; Vihalemm T; Zilmer M
    Clin Nephrol; 2001 Oct; 56(4):308-14. PubMed ID: 11680661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of oxidative stress before and after haemodialysis in chronic renal failure.
    Chugh SN; Jain S; Agrawal N; Sharma A
    J Assoc Physicians India; 2000 Oct; 48(10):981-4. PubMed ID: 11200923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
    Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH).
    Perna AF; Ingrosso D; Molino D; Galletti P; Montini G; Zacchello G; Bellantuono R; Caringella A; Fede C; Chimenz R; De Santo NG
    J Nephrol; 2003; 16(4):516-21. PubMed ID: 14696753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac troponin T and end stage renal disease.
    Gabr AE; Ibrahim IA; Aloulou SM; Al-Alfi MA; Al-Abdlrahim KA
    Saudi Med J; 2004 Aug; 25(8):1015-9. PubMed ID: 15322590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients.
    Phelan PJ; O'Kelly P; Walshe JJ; Conlon PJ
    Ren Fail; 2008; 30(4):423-9. PubMed ID: 18569917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
    Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients.
    Leinig C; Pecoits-Filho R; Nascimento MM; Gonçalves S; Riella MC; Martins C
    J Ren Nutr; 2008 Sep; 18(5):424-9. PubMed ID: 18721737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.